Alnylam PharmaceuticalsALNY 
$243.250.41%24h
0.41%24h
Global rank568
Market cap$30.38B
Change 7d-3.61%
YTD Performance-
SP500 benchmark
P/E-69.11
P/S16.62
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals ALNY Earnings
Earnings in 2024: $-440.24M
According to Alnylam Pharmaceuticals latest financial reports the company had earnings of $-440.24M in 2023-12-31, an decrease of -61.08% to 2023.
Alnylam Pharmaceuticals Earnings History from 2020 to 2025
-
Value:-
Alnylam Pharmaceuticals Annual Earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$440.24M | -61.08% |
| 2022 | -$1.13B | 32.64% |
| 2021 | -$852.82M | -0.64% |
| 2020 | -$858.28M | - |
View the top earning stocks 
